Press Releases – DELiver Therapeutics

Ponce Aurora Appoints Former Estee Lauder Executive as Chief Commercial Officer Ahead of Longevity Product Launches

Ponce Aurora is developing consumer products powered by its proprietary MitoXcel™ Technology, the first information- and AI-driven mitochondrial-targeted geropeptides addressing a fundamental cause of aging. Appointment strengthens leadership team to drive market readiness for YUUTH- and…

Edward Galli In Press Releases

PrintBio Contributes 3D Bioprinting Expertise to ARPA-H PRINT Program for Kidney Bioprinting

PrintBio, a regenerative medicine and bioprinting company, today announced its participation in a major ARPA-H PRINT Program initiative aimed at addressing the nation’s growing organ shortage through the development of…

egalli In News, Press Releases

Brent Saunders Appointed as Advisory Board Chairman

Saunders was previously CEO of Allergan, the company that developed and launched Botox™ until the company’s $63 billion acquisition by AbbVie Inc. in 2020 Miami, FL – February 26, 2025...

Danny Tetzl In Press Releases

Rapha Capital BioVentures Fund I Launches DELIVER Therapeutics Inc. with $3 Million Convertible Note Financing

DELIVER Therapeutics, Inc. (“DELIVER”) a company that plans to apply novel, high-throughput screening technologies combined with chemical innovation to DELIVER therapeutics that address the most difficult problems in clinical medicine has been launched with an initial $3M Convertible Note financing by Rapha Capital BioVentures Fund I, LP